Cargando…

Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases

BACKGROUND: Serum transferrin levels represent an independent predictor of mortality in patients with liver failure. Hepatocyte nuclear factor 4 alpha (HNF4α) is a master regulator of hepatocyte functions. The aim of this study was to explore whether serum transferrin reflects HNF4α activity. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Guldiken, Nurdan, Argemi, Josepmaria, Gurbuz, Berivan, Atkinson, Stephen R., Oliverius, Martin, Fila, Petr, Hamesch, Karim, Bruns, Tony, Cabezas, Joaquín, Lozano, Juan J., Mann, Jelena, Cao, Sheng, Mathurin, Philippe, Shah, Vijay H., Trautwein, Christian, Thursz, Mark R., Bataller, Ramon, Strnad, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887823/
https://www.ncbi.nlm.nih.gov/pubmed/33593348
http://dx.doi.org/10.1186/s12916-021-01917-6
_version_ 1783652053480898560
author Guldiken, Nurdan
Argemi, Josepmaria
Gurbuz, Berivan
Atkinson, Stephen R.
Oliverius, Martin
Fila, Petr
Hamesch, Karim
Bruns, Tony
Cabezas, Joaquín
Lozano, Juan J.
Mann, Jelena
Cao, Sheng
Mathurin, Philippe
Shah, Vijay H.
Trautwein, Christian
Thursz, Mark R.
Bataller, Ramon
Strnad, Pavel
author_facet Guldiken, Nurdan
Argemi, Josepmaria
Gurbuz, Berivan
Atkinson, Stephen R.
Oliverius, Martin
Fila, Petr
Hamesch, Karim
Bruns, Tony
Cabezas, Joaquín
Lozano, Juan J.
Mann, Jelena
Cao, Sheng
Mathurin, Philippe
Shah, Vijay H.
Trautwein, Christian
Thursz, Mark R.
Bataller, Ramon
Strnad, Pavel
author_sort Guldiken, Nurdan
collection PubMed
description BACKGROUND: Serum transferrin levels represent an independent predictor of mortality in patients with liver failure. Hepatocyte nuclear factor 4 alpha (HNF4α) is a master regulator of hepatocyte functions. The aim of this study was to explore whether serum transferrin reflects HNF4α activity. METHODS: Factors regulating transferrin expression in alcoholic hepatitis (AH) were assessed via transcriptomic/methylomic analysis as well as chromatin immunoprecipitation coupled to DNA sequencing. The findings were corroborated in primary hepatocytes. Serum and liver samples from 40 patients with advanced liver disease of multiple etiologies were also studied. RESULTS: In patients with advanced liver disease, serum transferrin levels correlated with hepatic transferrin expression (r = 0.51, p = 0.01). Immunohistochemical and biochemical tests confirmed reduced HNF4α and transferrin protein levels in individuals with cirrhosis. In AH, hepatic gene-gene correlation analysis in liver transcriptome revealed an enrichment of HNF4α signature in transferrin-correlated transcriptome while transforming growth factor beta 1 (TGFβ1), tumor necrosis factor α (TNFα), interleukin 1 beta (IL-1β), and interleukin 6 (IL-6) negatively associated with transferrin signature. A key regulatory region in transferrin promoter was hypermethylated in patients with AH. In primary hepatocytes, treatment with TGFβ1 or the HNF4α inhibitor BI6015 suppressed transferrin production, while exposure to TNFα, IL-1β, and IL-6 had no effect. The correlation between hepatic HNF4A and transferrin mRNA levels was also seen in advanced liver disease. CONCLUSIONS: Serum transferrin levels constitute a prognostic and mechanistic biomarker. Consequently, they may serve as a surrogate of impaired hepatic HNF4α signaling and liver failure. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-01917-6.
format Online
Article
Text
id pubmed-7887823
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78878232021-02-22 Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases Guldiken, Nurdan Argemi, Josepmaria Gurbuz, Berivan Atkinson, Stephen R. Oliverius, Martin Fila, Petr Hamesch, Karim Bruns, Tony Cabezas, Joaquín Lozano, Juan J. Mann, Jelena Cao, Sheng Mathurin, Philippe Shah, Vijay H. Trautwein, Christian Thursz, Mark R. Bataller, Ramon Strnad, Pavel BMC Med Research Article BACKGROUND: Serum transferrin levels represent an independent predictor of mortality in patients with liver failure. Hepatocyte nuclear factor 4 alpha (HNF4α) is a master regulator of hepatocyte functions. The aim of this study was to explore whether serum transferrin reflects HNF4α activity. METHODS: Factors regulating transferrin expression in alcoholic hepatitis (AH) were assessed via transcriptomic/methylomic analysis as well as chromatin immunoprecipitation coupled to DNA sequencing. The findings were corroborated in primary hepatocytes. Serum and liver samples from 40 patients with advanced liver disease of multiple etiologies were also studied. RESULTS: In patients with advanced liver disease, serum transferrin levels correlated with hepatic transferrin expression (r = 0.51, p = 0.01). Immunohistochemical and biochemical tests confirmed reduced HNF4α and transferrin protein levels in individuals with cirrhosis. In AH, hepatic gene-gene correlation analysis in liver transcriptome revealed an enrichment of HNF4α signature in transferrin-correlated transcriptome while transforming growth factor beta 1 (TGFβ1), tumor necrosis factor α (TNFα), interleukin 1 beta (IL-1β), and interleukin 6 (IL-6) negatively associated with transferrin signature. A key regulatory region in transferrin promoter was hypermethylated in patients with AH. In primary hepatocytes, treatment with TGFβ1 or the HNF4α inhibitor BI6015 suppressed transferrin production, while exposure to TNFα, IL-1β, and IL-6 had no effect. The correlation between hepatic HNF4A and transferrin mRNA levels was also seen in advanced liver disease. CONCLUSIONS: Serum transferrin levels constitute a prognostic and mechanistic biomarker. Consequently, they may serve as a surrogate of impaired hepatic HNF4α signaling and liver failure. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-01917-6. BioMed Central 2021-02-17 /pmc/articles/PMC7887823/ /pubmed/33593348 http://dx.doi.org/10.1186/s12916-021-01917-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Guldiken, Nurdan
Argemi, Josepmaria
Gurbuz, Berivan
Atkinson, Stephen R.
Oliverius, Martin
Fila, Petr
Hamesch, Karim
Bruns, Tony
Cabezas, Joaquín
Lozano, Juan J.
Mann, Jelena
Cao, Sheng
Mathurin, Philippe
Shah, Vijay H.
Trautwein, Christian
Thursz, Mark R.
Bataller, Ramon
Strnad, Pavel
Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases
title Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases
title_full Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases
title_fullStr Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases
title_full_unstemmed Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases
title_short Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases
title_sort serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887823/
https://www.ncbi.nlm.nih.gov/pubmed/33593348
http://dx.doi.org/10.1186/s12916-021-01917-6
work_keys_str_mv AT guldikennurdan serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT argemijosepmaria serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT gurbuzberivan serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT atkinsonstephenr serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT oliveriusmartin serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT filapetr serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT hameschkarim serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT brunstony serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT cabezasjoaquin serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT lozanojuanj serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT mannjelena serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT caosheng serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT mathurinphilippe serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT shahvijayh serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT trautweinchristian serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT thurszmarkr serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT batallerramon serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases
AT strnadpavel serumtransferrinasabiomarkerofhepatocytenuclearfactor4alphaactivityandhepatocytefunctioninliverdiseases